• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醋酸艾司利卡西平用于治疗神经性疼痛、头痛及颅神经痛:证据与经验

Eslicarbazepine acetate for neuropathic pain, headache, and cranial neuralgia: Evidence and experience.

作者信息

Alcántara Montero A, Sánchez Carnerero C I

机构信息

Unidad del Dolor, Hospital Don Benito-Villanueva de la Serena, Don Benito (Badajoz), España.

Servicio de Cirugía General y Digestiva, Hospital San Pedro de Alcántara, Cáceres, España.

出版信息

Neurologia (Engl Ed). 2019 Jul-Aug;34(6):386-395. doi: 10.1016/j.nrl.2016.11.009. Epub 2017 Feb 16.

DOI:10.1016/j.nrl.2016.11.009
PMID:28215909
Abstract

INTRODUCTION

Eslicarbazepine acetate (ESL), together with carbamazepine and oxcarbazepine, belongs to the dibenzazepine family. According to the latest clinical practice guidelines, tricyclic antidepressants, dual antidepressants (venlafaxine, duloxetine), and some antiepileptics (gabapentin, pregabalin) are first-line drugs for neuropathic pain; tramadol, lidocaine 5% patches, and capsaicin 8% patches are considered second-line drugs; and strong opioids constitute a third line of treatment. Such other antiepileptics as lamotrigine and lacosamide are not authorised as treatments for neuropathic pain by the regulatory agencies, but are nonetheless prescribed off-label in routine clinical practice. Carbamazepine, on the other hand, is indicated for trigeminal and glossopharyngeal neuralgia.

DEVELOPMENT

We conducted a literature search to gather evidence on the use of ESL for neuropathic pain, headache, and cranial neuralgia.

CONCLUSIONS

Evidence is insufficient to recommend ESL for neuropathic pain, headache, and cranial neuralgia. Most of the available evidence comes from open and observational studies with small sample sizes and no control group; however, their favourable results call for further studies on the usefulness of ESL for neuropathic pain, headache, and cranial neuralgia.

摘要

引言

醋酸艾司卡巴喷丁(ESL)与卡马西平和奥卡西平同属二苯并氮䓬类。根据最新临床实践指南,三环类抗抑郁药、双重作用抗抑郁药(文拉法辛、度洛西汀)以及一些抗癫痫药(加巴喷丁、普瑞巴林)是治疗神经性疼痛的一线药物;曲马多、5%利多卡因贴剂和8%辣椒素贴剂被视为二线药物;强效阿片类药物构成第三线治疗方案。其他抗癫痫药如拉莫三嗪和左乙拉西坦未获监管机构批准用于治疗神经性疼痛,但在常规临床实践中仍有超说明书用药的情况。另一方面,卡马西平适用于三叉神经痛和舌咽神经痛。

进展

我们进行了文献检索,以收集有关ESL用于神经性疼痛、头痛和颅神经痛的证据。

结论

证据不足,无法推荐ESL用于神经性疼痛、头痛和颅神经痛。现有证据大多来自样本量小且无对照组的开放性和观察性研究;然而,其良好结果表明需要进一步研究ESL用于神经性疼痛、头痛和颅神经痛的有效性。

相似文献

1
Eslicarbazepine acetate for neuropathic pain, headache, and cranial neuralgia: Evidence and experience.醋酸艾司利卡西平用于治疗神经性疼痛、头痛及颅神经痛:证据与经验
Neurologia (Engl Ed). 2019 Jul-Aug;34(6):386-395. doi: 10.1016/j.nrl.2016.11.009. Epub 2017 Feb 16.
2
[Lacosamide and neuropathic pain, a review].[拉科酰胺与神经性疼痛,综述]
Rev Neurol. 2016 Mar 1;62(5):223-9.
3
[Update in the pharmacological treatment of neuropathic pain].[神经病理性疼痛药物治疗的进展]
Semergen. 2019 Nov-Dec;45(8):535-545. doi: 10.1016/j.semerg.2019.05.008. Epub 2019 Jul 20.
4
[Drug treatment for neuropathic pain].[神经性疼痛的药物治疗]
Presse Med. 2008 Feb;37(2 Pt 2):346-53. doi: 10.1016/j.lpm.2007.07.023. Epub 2008 Jan 4.
5
Medical management of trigeminal neuropathic pains.三叉神经病理性疼痛的医学管理。
Expert Opin Pharmacother. 2010 Jun;11(8):1239-54. doi: 10.1517/14656561003767449.
6
EFNS guidelines on pharmacological treatment of neuropathic pain.欧洲神经科学联合会(EFNS)关于神经性疼痛药物治疗的指南。
Eur J Neurol. 2006 Nov;13(11):1153-69. doi: 10.1111/j.1468-1331.2006.01511.x.
7
Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia.评估乙琥胺治疗三叉神经痛的疗效和安全性。
Eur J Pain. 2018 Jul;22(6):1080-1087. doi: 10.1002/ejp.1192. Epub 2018 Feb 12.
8
Lamotrigine in the treatment of pain syndromes and neuropathic pain.拉莫三嗪在疼痛综合征和神经性疼痛治疗中的应用
Bratisl Lek Listy. 2008;109(9):421-4.
9
The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors.醋酸艾司利卡西平在三叉神经痛、神经性疼痛和内脏痛模型中的疗效:5-HT1B/1D 5-羟色胺能受体和CB1/CB2大麻素受体的作用
Anesth Analg. 2015 Dec;121(6):1632-9. doi: 10.1213/ANE.0000000000000953.
10
[Pharmacological treatment of neuropathic pain in primary care].[基层医疗中神经性疼痛的药物治疗]
Rev Prat. 2013 Jun;63(6):795-802.

引用本文的文献

1
Eslicarbazepine acetate, an alternative for patients with trigeminal neuralgia with hyponatremia induced by carbamazepine or oxcarbazepine.醋酸艾司利卡西平,用于治疗由卡马西平或奥卡西平诱发低钠血症的三叉神经痛患者的替代药物。
J Family Med Prim Care. 2024 Nov;13(11):5430-5431. doi: 10.4103/jfmpc.jfmpc_568_24. Epub 2024 Nov 18.
2
[Is there scientific evidence for the use of perampanel in neuropathic pain?].[吡仑帕奈用于神经性疼痛是否有科学依据?]
Rev Neurol. 2022 Jul 1;75(1):21-22. doi: 10.33588/rn.7501.2022170.
3
[Pharmacological approach to neuropathic pain: past, present and future].
[神经性疼痛的药理学治疗方法:过去、现在与未来]
Rev Neurol. 2022 Apr 16;74(8):269-279. doi: 10.33588/rn.7408.2021381.
4
[Differential pharmacological aspects between voltage-gated sodium channel blockers: implications in clinical practice].[电压门控钠通道阻滞剂之间的药理学差异:对临床实践的影响]
Aten Primaria. 2021 Jan;53(1):119-121. doi: 10.1016/j.aprim.2020.06.007. Epub 2020 Sep 21.
5
Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments.三叉神经痛:从病理生理学到药物治疗的概述。
Mol Pain. 2020 Jan-Dec;16:1744806920901890. doi: 10.1177/1744806920901890.
6
Risk factors for postoperative delirium in patients undergoing microvascular decompression.微血管减压术后谵妄的危险因素。
PLoS One. 2019 Apr 18;14(4):e0215374. doi: 10.1371/journal.pone.0215374. eCollection 2019.